Lizzie Deignan: Chris Froome's reputation has been unfairly damaged by salbutamol case
'Unfortunately people have made up their minds, and that is not based on the full story'

Chris Froome on the attack during stage 19 of the Giro d’Italia
Chris Froome's ongoing salbutamol case from the Vuelta a España has been handled unfairly and Froome's reputation damaged whatever the eventual outcome, says Lizzie Deignan.
The case is still being investigated by the UCI and should have remained confidential. However the case was leaked to The Guardian and Le Monde in December, leading to months of speculation over the case.
Froome, who has denied any wrongdoing and has vowed to clear his name, tested over the allowed limit for salbutamol on his way to winning the 2017 Vuelta a España in September. The process of gathering and reviewing scientific and legal papers continues with a decision now not expected until After the Tour de France in July.
>>> France vs Froome: Why Chris Froome can expect a more hostile reception at the Tour de France
"He hasn't had a fair process because unfortunately people have made up their minds, and that is not based on the full story," Deignan told Orla Chennaoui on her When Orla Met podcast.
"Unfortunately for Chris his reputation is tarnished and will be for ever. Whether he's innocent or not, it's kind of irrelevant to some people at this stage. A leak in a legal process should never happen."
The Guardian and Le Monde newspapers reported the test result and initial stages of the process on December 13. Since then the case has been debated in the court of public opinion while Froome continues to race, winning the Giro d'Italia in May.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
"A rider should be protected because inevitably there will be things that happen, grey areas that should be looked at logically, scientifically, and analysed in court," Deignan added.
"That's an inevitable part of having asthma and taking an inhaler and I think unfortunately he hasn't had a fair process. It's a very personal story."
According to The Times in May, his Froome's legal team will to draw on a new scientific report by Dutch researchers who say that WADA's salbutamol test is unsafe given that levels in urine can vary wildly. According to the researchers as many as 15.4% of the tests could produce false positives and putting the presumption of guilt on the athlete is "completely unacceptable".
With his case being debated publicly while legal proceedings are still ongoing, Froome has said that he is continuing to concentrate on his racing and is confident that he will be cleared of any wrongdoing.
"I certainly have got a clear conscious," Froome said last month. "Like I've said, once the time is right, we will share the information with everyone, and I am sure they will see it from our point of view."
Deignan avoided a ban of her own in 2016 due to issues with the whereabouts procedure along with missed tests. The former world champion was provisionally suspended by UK Anti-Doping for missing multiple tests within a 12-month period, but was subsequently cleared by the Court of Arbitration for Sport after proving that an anti-doping official did not make sufficient efforts to contact her when trying to carry out one of the tests.
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Gregor Brown is an experienced cycling journalist, based in Florence, Italy. He has covered races all over the world for over a decade - following the Giro, Tour de France, and every major race since 2006. His love of cycling began with freestyle and BMX, before the 1998 Tour de France led him to a deep appreciation of the road racing season.
-
'I completely blew my doors' - Katie Archibald wins first national track title in six years
Double Olympic champion enjoys "nice reset" on National Track Championships return
By Tom Davidson Published
-
Madison DTE Men’s Isoler Thermal Long Sleeve Jacket review: best for early spring warmth
Mid-weight warmth and a reasonable price tag make the DTE Isoler Thermal Long Sleeve Jacket well worth a look for cool spring and autumn rides
By Tim Russon Published
-
Chris Froome is 'keeping the door open' to racing in 2026 - could he ride on?
39-year-old says his retirement isn't concrete yet
By Tom Davidson Published
-
Chris Froome misses out on Tour de France selection
39-year-old absent from Israel-Premier Tech's eight-rider roster
By Tom Davidson Published
-
A complete history of Ineos Grenadiers kits, from Adidas to Gobik, via Rapha
The British team switch to Gobik in 2024 after two years with Bioracer
By Tom Thewlis Published
-
Chris Froome's boss rubbishes claims bike fit is behind lack of results
'He can talk about his bike position until the cows come home - that's still not going to earn him a position on a Grand Tour team' says Israel-Premier Tech team owner Sylvan Adams
By Tom Thewlis Published
-
Chris Froome, rim brake evangelist, 'warms to' disc brakes
The Israel-Premier Tech rider, also an investor at Factor Bikes, says that he has "way less problems" with discs these days
By Adam Becket Published
-
Is Chris Froome - in 2023 - a professional cyclist, or an influencer?
The seven-time Grand Tour winner hasn't raced since July, but has taken to being interesting on social media
By Adam Becket Published
-
Chris Froome 'absolutely not' worth multi-million euro salary says his team boss
The four-time Tour de France winner was not selected for this year's Tour de France for performance reasons, Israel-Premier Tech boss Sylvan Adams says
By Chris Marshall-Bell Published
-
Chris Froome not selected for Tour de France 2023
38-year-old misses out on 'ultimate goal' as Israel-Premier Tech confirm eight-man squad
By Tom Davidson Published